Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.
TALL-104 is a human leukemic T cell line that expresses markers characteristic of both cytotoxic T lymphocytes and natural killer cells. TALL-104 cells are potent tumor killers, and the use of lethally irradiated TALL-104 as cellular therapy for a variety of tumors has been explored. We investigated the interactions of TALL-104 cells with human brain tumor cells. TALL-104 cells mediated increased lysis of a panel of brain tumor cells at low effector-to-target ratios over time. We obtained evidence that TALL-104 cells injured glioma cells by both apoptotic and necrotic pathways. A 7-amino actinomycin D flow cytometry assay revealed that the percentages of both apoptotic and necrotic glioma cells increased after TALL-104 cell/glioma cell coincubations. Fluorescent microscopy studies and a quantitative morphologic assay confirmed that TALL-104 cell/glioma cell interactions resulted in tumor cell apoptosis. Cytokines are secreted when TALL-104 cells are coincubated with brain tumor cells; however, morphologic analysis assays revealed that the soluble factors contained within clarified supernates obtained from 4 h coincubates added back to brain tumor cell cultures did not trigger the glioma apoptosis. TALL-104 cells do not express Fas ligand, even upon coincubation with glioma targets, which suggests that the Fas/Fas ligand apoptotic pathway is not likely responsible for the cell injury observed. We obtained evidence that cell injury is calcium dependent and that lytic granule exocytosis is triggered by contact of TALL-104 cells with human glioma cells, suggesting that this pathway mediates glioma cell apoptosis and necrosis.
Gomez
German G
GG
Department of Pathology, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Read
Susana B
SB
Gerschenson
Lazaro E
LE
Santoli
Daniela
D
Zweifach
Adam
A
Kruse
Carol A
CA
D017209:Apoptosis / Q000276:immunology; D001932:Brain Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D002450:Cell Communication / Q000276:immunology*; D045744:Cell Line, Tumor; D018920:Coculture Techniques / Q000379:methods; D016207:Cytokines / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D005910:Glioma / Q000473:pathology; D006801:Humans; D015458:Leukemia, T-Cell / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D009336:Necrosis; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism / Q000528:radiation effects
D016207:Cytokines